In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, INmune Bio Inc’s stock clocked out at $2.42, up 8.04% from its previous closing price of $2.24. In other words, the price has increased by $8.04 from its previous closing price. On the day, 1.97 million shares were traded. INMB stock price reached its highest trading level at $2.48 during the session, while it also had its lowest trading level at $2.2401.
Ratios:
To gain a deeper understanding of INMB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $23.Rodman & Renshaw initiated its Buy rating on January 28, 2025, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 30 ’24 when Moss David J bought 10,000 shares for $5.29 per share. The transaction valued at 52,868 led to the insider holds 1,285,869 shares of the business.
Tesi Raymond Joseph bought 15,380 shares of INMB for $98,048 on Sep 12 ’24. The President and CEO now owns 1,554,106 shares after completing the transaction at $6.38 per share. On Sep 12 ’24, another insider, Moss David J, who serves as the Chief Financial Officer of the company, bought 7,690 shares for $6.38 each. As a result, the insider paid 49,024 and bolstered with 1,275,869 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 65921044 and an Enterprise Value of 34625972. For the stock, the TTM Price-to-Sale (P/S) ratio is 1286.80 while its Price-to-Book (P/B) ratio in mrq is 1.87. Its current Enterprise Value per Revenue stands at 692.519.
Stock Price History:
The Beta on a monthly basis for INMB is 0.96, which has changed by -0.7166276 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, INMB has reached a high of $11.64, while it has fallen to a 52-week low of $1.89. The 50-Day Moving Average of the stock is -59.06%, while the 200-Day Moving Average is calculated to be -62.77%.
Shares Statistics:
It appears that INMB traded 2.59M shares on average per day over the past three months and 1936440 shares per day over the past ten days. A total of 22.93M shares are outstanding, with a floating share count of 18.90M. Insiders hold about 28.90% of the company’s shares, while institutions hold 27.91% stake in the company. Shares short for INMB as of 1749772800 were 7256955 with a Short Ratio of 4.02, compared to 1747267200 on 5870122. Therefore, it implies a Short% of Shares Outstanding of 7256955 and a Short% of Float of 38.48.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
